Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alexion Pharmaceuticals I...

    NASDAQ: ALXN · Real-Time Price · USD
    182.50
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Alexion Pharmaceuticals Statistics

    Share Statistics

    Alexion Pharmaceuticals has 0 shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 56.73 and the forward PE ratio is null. Alexion Pharmaceuticals's PEG ratio is -0.76.

    PE Ratio

    n/a
    		 56.73

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 5.64

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.94

    P/FCF Ratio

    n/a
    		 11.82

    PEG Ratio

    n/a
    		 -0.76
    Financial Ratio History

    Enterprise Valuation

    Alexion Pharmaceuticals has an Enterprise Value (EV) of 33.83B.

    EV / Sales

    n/a
    		 5.57

    EV / EBITDA

    n/a
    		 33.73

    EV / EBIT

    n/a
    		 11.27

    EV / FCF

    n/a
    		 11.68

    Financial Position

    The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.22.

    Current Ratio

    n/a
    		 3.59

    Quick Ratio

    n/a
    		 3.11

    Debt / Equity

    n/a
    		 0.22

    Debt / EBITDA

    n/a
    		 2.55

    Debt / FCF

    n/a
    		 0.88

    Interest Coverage

    n/a
    		 27.32

    Financial Efficiency

    Return on Equity is 5.18% and Return on Invested Capital is 21.34%.

    Return on Equity

    n/a
    		 5.18%

    Return on Assets

    n/a
    		 3.33%

    Return on Invested Capital

    n/a
    		 21.34%

    Revenue Per Employee

    n/a
    		 $1,581,939.01

    Profits Per Employee

    n/a
    		 $157,258.27

    Employee Count

    n/a
    		 3,837

    Asset Turnover

    n/a
    		 0.34

    Inventory Turnover

    n/a
    		 0.71

    Taxes

    Income Tax

    n/a
    		 -34.4M

    Effective Tax Rate

    n/a
    		 -6.05%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 1.26, so Alexion Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.26

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 n/a

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 n/a

    Average Volume (20 Days)

    n/a
    		 4,222,993

    Income Statement

    In the last 12 months, Alexion Pharmaceuticals had revenue of 6.07B and earned 603.4M in profits. Earnings per share was 2.75.

    Revenue

    n/a
    		 6.07B

    Gross Profit

    n/a
    		 5.52B

    Operating Income

    n/a
    		 2.86B

    Net Income

    n/a
    		 603.4M

    EBITDA

    n/a
    		 1B

    EBIT

    n/a
    		 673.7M

    Earnings Per Share (EPS)

    n/a
    		 2.75
    Full Income Statement

    Balance Sheet

    The company has 2.96B in cash and 2.56B in debt, giving a net cash position of 402.5M.

    Cash & Cash Equivalents

    n/a
    		 2.96B

    Total Debt

    n/a
    		 2.56B

    Net Cash

    n/a
    		 402.5M

    Retained Earnings

    n/a
    		 5.24B

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 3B and capital expenditures -106.7M, giving a free cash flow of 2.9B.

    Operating Cash Flow

    n/a
    		 3B

    Capital Expenditures

    n/a
    		 -106.7M

    Free Cash Flow

    n/a
    		 2.9B

    FCF Per Share

    n/a
    		 13.22
    Full Cash Flow Statement

    Margins

    Gross margin is 90.88%, with operating and profit margins of 47.12% and 9.94%.

    Gross Margin

    n/a
    		 90.88%

    Operating Margin

    n/a
    		 47.12%

    Pretax Margin

    n/a
    		 9.37%

    Profit Margin

    n/a
    		 9.94%

    EBITDA Margin

    n/a
    		 16.53%

    EBIT Margin

    n/a
    		 47.12%

    FCF Margin

    n/a
    		 47.71%

    Dividends & Yields

    ALXN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 1.76%

    FCF Yield

    n/a
    		 8.46%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ALXN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 23, 2011. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 May 23, 2011

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist